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A b s t r a c t  
Nano-aggregates of N-acetyl-N-carboxymethyl chitosan (NCac) were studied at 0.5 mg.mL-1 using 
pyrene fluorimetry analysis in 0.1 mol.L-1 phosphate buffer (pH 7.4). The size and morphology of the 
aggregates were determined by dynamic light scattering and atomic force microscopy. The stability 
of the particles for periods up to 20 h in buffer was determined. Camptothecin was entrapped in the 
particles using various methods and the rate constant for drug release (k) was determined. Lower k 
values indicate strong interactions between the drug and the hydrophobic core of the polymeric 
micelles.  
Keywords:N-acetyl-N-carboxymethyl chitosan; nanoaggregation; nanoparticle; light-scattering 
(dynamic); stability, controlled release. 
 
Introduction 
Polymers and amphiphilic co-polymers have emerged as new 
materials with applications in the pharmaceutical and cosmetic 
industries, in addition to molecular biology; they are utilized 
because they can form spherical micelles and capsular 
nanostructures [1-5]. Polymeric micelles have become attractive 
drug and gene delivery devices; the hydrophobic core acts as a 
reservoir for lipophilic drugs, while the hydrophilic surface acts as 
an interface between the aqueous phase and the hydrophobic core 
[6-8].Chitosan is a polymer used for aggregate and micelle 
formation. However, because it has limited solubility, different 
chemical modifications were developed, such as 
carboxymethylation, to overcome this restrictive characteristic [9-
14]. The chitosan-derived polymeric micelles could be used for 
entrapment of hydrophobic drugs, which include taxol [15], 
paclitaxel [10], camptothecin [5] and 5-fluorouracil [16]. 
Camptothecin (CPT), which is an alkaloid from Camptotheca 
acuminate, is a potent drug used in the treatment for solid 
gallbladder, stomach and rectum tumors, as well as leukemia. CPT 
maintains an equilibrium between lactone and carboxylate forms. 
The lactone form of CPT is active, but because the carboxylate 
groups have a high affinity for albumin at physiological pH, the 
equilibrium rapidly shifts to favor the inactive carboxylate form [17]. 
The derivatization of CPT and the entrapment of the parent drug in 
nanostructures have become two major strategies utilized to 
improve lactone stability and aqueous solubility.  
The use of polymeric nanoparticles may promote the delivery of 
CPT into tumor sites because of their small size and enhanced 
penetrative ability into vessels, as well as their interactions with 
specific parts of the human body [18,19]. Efforts to improve these 
particles have focused on higher drug loading, more efficient drug 
delivery, and resistance against both chemical and biological 
degradation [20,21].  
We evaluated the chemical formation and acetylation of N-
carboxymethyl chitosan, as well as the conditions for the 
nanoaggregation of the product, N-acetyl-N-carboxymethyl 
chitosan (NCac). Additionally, the stability of the nanoaggregates in 
solution, loading capacity for camptothecin, and kinetics of drug 
release were evaluated. Nanoaggregation of NCac could create 
new, stable particles in solution with the ability to encapsulate 
lipophilic drugs and prolong drug release. 
Materials and Methods 
Chitosan, N-carboxymethylchitosan, N-acetyl-N-
carboxymethylchitosan and camptothecin 
Chitosan from shrimp shells was obtained commercially from China 
(Shangyu Biotech Co., Ltd). N-carboxymethylation of chitosan (NC) 
(Figure. 1A) with glyoxylic acid was performed as previously 
described [22-24]. For every 3.5 g of chitosan added to 1 L of 
acetic acid (0.1 mol.L-1, pH = 4.5, after 24 h of stirring), a 50% 
glyoxylic acid solution was added to obtain derivatives with 50% 
theoretical carboxymethylation. The mixtures were mechanically 
stirred for 24 h before the pH was adjusted to 8.0 with 0.1 mol.L-1 
of NaOH. Subsequently, a 2% solution of NaBH4 was added. The 
reaction was stirred for an additional 24 h. Next, the pH was 
adjusted to 6ă8 and the system was filtered under vacuum. The 
filtered product (NC) was precipitated using 3 L of ethanol and 
dried at room temperature (25oĈC) under vacuum.  
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To re-acetylate NC, 2.0 g were dispersed in 100 mmol.L-1 of acetic 
acid (100 mL). The sample was diluted with 250 mL of methanol 
and a solution of acetic anhydride in methanol was added. In this 
work, we used 0.2 equivalents of acetic anhydride relative to N-
carboxymethylchitosan because higher amounts created a material 
that was completely insoluble in water. After 24 hours, the polymer 
was precipitated with 1 L of ethanol, filtered through a nylon cloth, 
washed and dried under a vacuum at room temperature (25ĈC), 
which completed the formation of N-acetyl-N-
carboxymethylchitosan (NCac) (Figure. 1B). 
The degree of NC carboxymethylation was evaluated by both 
titration and by 1H-NMR. A titration curve was constructed by 
dissolving 0.25 g of NC in 100 mL of water, bringing the solution to 
~ pH 2 with 0.1 mol.L-1 HCl (titrated with 0.1 mol.L-1 NaOH). The 
degree of carboxymethylation determined by 1H-NMR was 
calculated using the H2 signal proton from ăCH2- of glyoxylic acid 
and using the following equation:  
 eq. 1 
Camptothecin (Figure. 1C) was obtained from Sigma-Aldrich and 
had a molar mass of 348.35 g.moL-1, a molecular formula of 
C20H16N2O4, a pKa of 10.8 and a log P of 0.95; this information 
was provided by the supplier. 
 
 
 
Figure 1. Schematic representation of 1A: N-carboxymethylchitosan (NC); 1B: N-acetyl-N-carboxymethylchitosan (NCac) and 1C: camptothecin. 
 
Characterization of NCac 
NCac was characterized by FTIR [25], 1H and bidimensional 1H-
13C- NMR. The FTIR analysis was performed in a Hartmann and 
Braumn MB-series instrument and samples were immobilized in 
KBr. The acquisition range for the FTIR study was 400 to 4000 cm-
1 and the resolution was 2 cm-1; samples were constructed using 2 
mg of NCac and 100 mg of KBr.  
1H-NMR was also used to calculate the degree of acylation (DDA). 
The samples (10 mg.mL-1) were repeatedly dissolved in D2O, 
which resulted in complete deuterium exchange, and was then 
freeze-dried (3 times). 1H-NMR and HMQC spectroscopic 
experiments were carried out using a 400 MHz Bruker model DRX 
Avance III NMR spectrometer, which incorporated a Fourier 
transform and used a 5 mm inverse gradient probe. Spectra were 
obtained at 80 ĈC and the chemical shifts are expressed in ppm (Ē). 
The DDA calculation from the 1H-NMR spectral data were 
determined using two different methods. The first method was 
based on the work of Hirai, Odani, and Nakajima [26]; the signal 
protons H2, H3, H4, H5, H6 and H6 from NCac were used in 
equation 2, below. The second method was based on the work of 
Lavertu [27]; the integrals of the proton H1 peak from a 
deacetylated monomer (H1D) and the peak from the acetyl group, 
which accounted for three protons (HAc), were used in equation 3, 
below. 
DDA(%) = 1− 1
3
HAc 1
6
H2+H3+H4+H5+H6⎛⎝⎜
⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟×100 eq. 2 
  
DDA(%) = H1D
H1D+HAc 3
⎛
⎝⎜
⎞
⎠⎟×100        eq. 3 
Bassani et al. International Journal of Drug Delivery 5 (2) 214-223 [2013] 
 
PAGE | 216 |
 
 
 
Stability studies of NCac by TDLS in different solvents 
 
Stability studies of NCac were performed by continuous 
measurement of dynamic light scattering at 90o, which was 
performed in NanoDLS equipment from Brookhaven Instruments 
Corporation. The raw voltage from the detector was used to 
measure the sample stability over 20 h at 25ĈC. Time dependence 
light scattering (TDLS) used 0.1 mol.L-1 phosphate buffer (pH 7.4) 
and a sample of NCac at 1 mg.mL-1. 
Polymeric molar mass determination 
For the GPC analysis, the experiments were carried out at 30ĈC in 
a Viscotek GPC Multi-detector. Refractive index (RI), light 
scattering (LS) and Malvern viscometer systems, which used an 
806HQ Shodex-OH pack column, were utilized in this experiment. 
The samples of NC and NCac (1 mg.mL-1) were solubilized in 
aqueous 0.1 mol.L-1 Tris-HCl buffer (pH 8.2), which contained 
0.02% (w/w) sodium azide, and filtered through a 0.45 μm pore-
diameter membrane, as previously described [14]. 
Surface tension studies and fluorescence assay 
The critical concentration for the aggregation of NCac was 
determined using concentrations from 1.0 x 10-2 to 5.0 mg.mL-1 in 
0.1 mol.L-1 phosphate buffer (pH 7.4). The surface-tension 
measurements were performed at 25 ĈC using a DataPhysics 
OCA15 plus tensiometer. The fluorescence assays, which used 
pyrene as a hydrophobic marker, were performed at a final 
concentration of 2 μmol.L-1, in addition to the same concentration 
of polymer used in the surface-tension measurements. The pyrene 
experiments used an excitation wavelength of 343 nm and 
emission wavelengths ranging from 360 to 500 nm; measurements 
were taken using a Hitachi F-4500 Fluorescence Spectrophotomer. 
The changes in vibratory bands I and III, which were at 373 and 
384 nm, respectively, were evaluated to understand the 
hydrophobic domains in the polymer [28].  
Characterization of NCac particles  
NCac samples at both 1 mg.mL-1 and 5 mg.mL-1 were evaluated in 
0.1 mol.L-1 phosphate buffer (pH 7.4) at temperatures ranging from 
25 to 75 ĈC, which were separated by increments of 5 ĈC. Colloidal 
stability, which was obtained as a function of temperature, was 
determined using NanoDLS equipment from Brookhaven 
Instruments Corporation. 
Topographical analyses were performed using a 5500 Agilent 
PicoPlus molecular imager in tapping-mode, which utilized a 
NSC14 silicon cantilever with a spring constant of 5 N.m-1 a and 
resonance frequency of 182 Hz. The data were analyzed using 
SPIPTM, Scanning Probe Image Processor software. 
Entrapment efficiency for camptothecin in NCac 
particles. 
CPT was incorporated into NCac using three different methods. 
The parent polymer NC exhibited a low capacity for drug-loading in 
preliminary studies and was not studied further. The equilibrium 
solubility of CPT in the absence and presence of the polymer was 
tested over the 72 h, which began after dispersion, in aqueous 
media. The three procedures for drug loading were:  
Method 1: The first method entailed the co-dispersion of 200 
μg.mL-1 CPT and 1000 μg.mL-1 NCac in 0.1 mol.L-1 phosphate 
buffer (pH 7.4).  
Method 2: A 1000 μg sample of CPT was solubilized in 1 mL 
chloroform and 0.7 mL acetonitrile. Next, 5000 μg of NCac was 
dispersed in this solution. The organic solvent was evaporated 
using a stream of nitrogen. Subsequently, 5 mL phosphate buffer 
(0.1 mol.L-1, pH 7.4) was added to the film and the sample was 
sonicated for 15 min. 
Method 3: Samples of 1000 μg CPT and 5000 μg NCac were co-
dispersed in 2 mL DMSO and subsequently dialyzed against 0.1 
mol.L-1 phosphate buffer (pH 7.4); the volume was adjusted to 5 
mL with the buffer. 
Free camptothecin was removed from the camptothecin entrapped 
in NCac nanoaggregates by centrifuging the samples (1,000 g), 
which worked by separating of the dispersed polymer/drug 
complex from the insoluble drug. 
The CPT entrapment efficiency (E) in NCac was calculated using 
the following equation: 
 
  eq. 4 
 
where CPTtotal is the total concentration of CPT and CPTFree is the 
free, insoluble camptothecin. CPT is insoluble in water, but the 
nanoaggregates of the NCac /CPT complex maintain a stable, 
colloidal dispersion in PBS buffer. 
The determination of the drug entrapment efficiency was performed 
using reverse-phase high-performance liquid chromatography. The 
chromatographic resolution was achieved on a Supelcosil LC-18 
column (15 cm x 4.6 mm id, 5 μm) using methanol and 10 mmol.L-
1 KH2PO4 (60 + 40, v/v; pH 2.8) as the mobile phase, which had a 
flow rate of 1.0 mL.min-1; ultraviolet detection was carried out at 
254 nm [29]. The calibration curve, which had a correlation 
coefficient of 0.999, was linear from 0.5 to 10.0 μg.mL-1 and the 
limits of quantitation (LQ) and determination (LD) were 0.25 and 
0.07 μg.mL-1, respectively. 
 
Kinetic studies of the drug release from particles 
 
In vitro studies of the release of CPT from the nanoparticles were 
performed using a cellulose ester dialysis membrane (6,000-8,000 
MWCO) from Spectrum Labs (Rancho Dominguez, CA), which was 
20 mm in diameter and previously wetted for 12 hours with the 
dissolution medium (0.1 mol.L-1 phosphate buffer (pH 7.4 or pH 
6.4), with 20% (v/v) of DMSO). Free CPT (200 μg.mL-1) in the 
dissolution medium, or nanoparticles in colloidal dispersion, which 
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were effectively at a concentration of 200 μg.mL-1 of CPT, were 
placed on a dialysis membrane.  
First order kinetics was applied as a model for drug release, as 
shown in equation 5: 
Drug(%) = Drug(%)f −Drug(%)0 (1− exp(−kt))  (eq. 5) 
 
where Drug(%)f is the final concentration in the medium, Drug (%)0 
is the initial concentration in the medium, k is the drug release 
constant, and t is the time. 
The membrane was affixed in a 250 mL Erlenmeyer flask 
containing 100 mL of the dissolution medium; this system was 
placed in a shaker with a rotation of 100 rpm at 37ĈC. Samples (2 
mL) were withdrawn at 0, 2, 4, 6, 8, 10, 12 and 15 hours and 
dissolution medium was added to replace the lost volume. CPT 
concentrations were determined by fluorescence spectroscopy, 
which utilized with excitation at 360 nm, emission at 465 nm and 
linearity from 7x10-3 to 7x10-2 mg.mL-1 (R 0.99); these experiments 
were performed using an F-4500 Fluorescence Spectrophotomer 
manufactured by Hitachi. 
Results and discussion  
Preparation and characterization of N-
carboxymethylated and acetylated derivatives  
NC and NCac were prepared and characterized as previously 
described [13]. As shown by the alkalimetric curve, NC exhibits 
50% carboxymethylation; its structure was initially compared with 
the structure of NCac by FTIR analysis. 
Characteristic absorption peaks were observed at 3000-4000 cm-1 
(-OH) and at 1750 cm-1 (C=O of the ăCOOH group) for both NC 
and NCac. The absorption peaks at 1650 cm-1 were assigned to 
the carbonyl stretch of the secondary amides (amide I band); the 
NăH bending vibration of the non-acylated 2-aminoglucose primary 
amines at 1570 cm-1 was clearly less prominent in the NCac 
sample. The acetyl group was observed at 2920 and 2870 cm-1 (C-
H stretching) and was a stronger signal in the N-acetylate sample 
(NCac) (data not shown). 
 
Table 1. Acetate free and N-acetyl determined by 1H NMR and Carboxymethyl group (%) using titration and 1H-NMR. 
Sample Carboxymethyl 
group (%) 
Acetyl group 
(%) 
Titration 1H-
NMR  
Free  
1H-NMR 
N-acetyl
1H-NMR 
Total (free+N-
acetyl) 
1H-NMR 
 
  Eq. 
2 
Eq.3 Eq. 2 Eq. 3
NC 50 44.2 12.5 17.0 3.0 3.5 18.0  
NCac - 42.4 11.3 15.2 15.6 22.1 32.1  
 
.  
The structures of NC and NCac were also confirmed by 1H and 1H-
13C NMR (Figure. 2) experiments. The evaluations of the 
carboxymethylation and DDA for both NC and NCac were based 
on 1H-NMR and calculated using equations 1, 2 and 3. The values 
for the carboxymethyl, free acetyl and N-acetyl experiments are 
shown in Table 1. 
The extent of carboxymethylation in NC and NCac were 44.2 and 
42.4%, respectively, by 1H-NMR and 50% by titration. The average 
values of total acetylation were similar in the FTIR and 1H-NMR 
data, with 30.0% and 32.1% acetylation, respectively; this result 
indicates that only 20% of the free amine groups persisted in the 
structure of NCac. However, quantitative 1H-NMR studies of the 
acetyl groups revealed two different forms. The ionically bound 
acetate on the amine group accounted for 11.3 to 15.2% (free 
acetyl) and the covalently bound N-acetyl groups accounted for 
15.6 to 22.1%; these values were determined using equation 2 and 
3, respectively. 
The structural modifications introduced by the re-acetylation of 
NCac are reflected in the HMQC spectra. The carbon and the 
hydrogen peaks are identified in Fig. 2C. The main difference 
between NC and NCac is the presence of N-acetyl groups, which 
are denoted by the signals at Ē 2.41 and Ē 24.5 in the 1H and 13C-
NMR spectra, respectively. The NC sample, which is a fully 
deacetylated sample (from 3.0% to 3.5% of N-acetyl groups), 
exhibits 12.5 to 17.0% ionically bound acetate.  
The NCac spectra present a more intense N-acetyl peak at these 
chemical shifts, which is because the acetylation occurs mostly at 
the free amine site on C-2. The identity of the peak at Ē 2.5, which 
was assigned to the ionically bound acetyl groups, was confirmed 
by doping both solutions with 0.052 mmol of acetic acid (data not 
shown) and subsequently observing a considerable increase in this 
peakÊs intensity [27]. 
All observed peaks could be correlated with those published 
previously [13, 30] and are exhibited in Figure. 2. These peak data 
confirmed the presence of N-carboxymethylation, which was the 
expected result of the reaction between glyoxylic acid and 
chitosan. The acetylation, which was carried out using acetic 
anhydride in methanol, promoted the reaction on the remaining 
amine groups in NC.  
This acetylation reaction involves the nucleophilic addition of an 
un-protonated primary amine, which is from glucosamine, to acetic 
anhydride. Since acetic anhydride is readily hydrolyzed by water,  
 Figur
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mixtures of methanol (MeOH) and water are typically used as the 
solvent when reacetylating chitosan. It is also known that chitosan 
is not soluble in 100% MeOH; therefore, the reaction could not be 
performed under conditions precluding the hydrolysis of acetic 
anhydride [31]. 
The acetylation of N-carboxymethylchitosan creates a hydrophobic 
core in the polymer structure, which will be evaluated below, and 
can consequently be used to carry relatively water-insoluble 
compounds, such as CPT. 
Stability of derivatives in different buffers and pHÊs 
 
N-acetyl-N-carboxymethylchitosan (NCac) demonstrated less 
aggregation and macromolecular behavior in alkaline buffer (pH 
8.2); this effect was due to the ionization of N-carboxymethyl 
group, which promoted electrostatic repulsion between the acid 
groups and generated more favorable conditions for polymer-
solvent interactions (Figure. 3).  
A 
B  
Figure 3. (A) Stability of NCac by TDLS using pH 7.4 at 25°C. (B) 
Dynamic light scattering  (Dh) of NCac in 0.1 mol.L-1 phosphate 
buffer pH 7.4 as a function of the temperature. 
Table 2. GPC results and chemical quantifications for NC and 
NCac in 0.1 mol.L-1 Tris-HCl pH 8.2.   
Sample NC NCac
Mw/10-5 g.moL-1 2.29  3.03
Mn /10-5 g.moL-1 0.230  0.362
Mpeak /10-5 g.moL-1 0.283  0.378
Mw/Mn 9.9 8.3
IV (dL.g-1) 0.297 0.370
 
 
Samples of NC and NCac, which were dispersed in 0.1 mol.L-1 
Tris-HCl buffer (pH 8.2), were used to study the systemsÊ 
macromolecular properties (Table 2). GPC analysis indicated that 
polydispersed samples (Mw/Mn from 9.9 to 8.3) had an intrinsic 
viscosity of 0.297 and 0.370 dL.g-1 and an Mw of 2.29 x 105 g.moL-
1 and 3.03 x 105 g.moL-1, respectively, for NC and NCac.  
Additionally, at pH 7.4, the equilibrium between carboxylic acid 
moieties and the bufferÊs phosphate groups was strongly 
influenced by the free amino groups; this perturbation of the 
equilibrium considerably diminished the favorable interactions with 
the solvent, which induced the formation of aggregates.  
The stability of the NCac aggregates was studied with a light 
scattering signal at 90Ĉ (Figure. 3A) in 0.1 molL-1 phosphate buffer 
(pH 7.4). The aggregates were stable for up to 20 h of analysis, 
which suggested that NCac would be a good candidate for drug 
entrapment and delivery. The hydrodynamic diameter (Dh) was 
also constant under these pH and temperature conditions (Fig. 3A). 
Particles with hydrodynamic diameters (Dh) at 99.2 and 74.4 nm, at 
25ĈC and 55ĈC, respectively, were analyzed by DLS (Fig. 3B); the 
nanoparticles were influenced by the temperature and the 
aggregates increased in size when the temperature rose. 
The morphology of the nanoparticles (Figure. 4) was analyzed 
using atomic force microscopy (AFM). The AFM analysis showed 
spherical particles, which had a mean diameter of 80.85 μ 18.50 
nm (n=30), deposited on mica at 25ĈC. The dimensions measured 
by AFM were similar to the Dh obtained by DLS analysis.  
According to Philippova et al [32], the nano-aggregation of chitin 
and chitosan is subject to 3 major parameters: 1) aggregation of 
chitosan derivatives modulated by hydrogen bonds; 2) 
crystallization of junction zones between different macromolecules, 
which make some hydrogen bonds inaccessible to urea or too 
stable to be broken; 3) strong hydrophobic bonds.  
Using the pyrene peak ratio, the aggregation in solution was 
determined to be 0.5 mgmL-1; it was observed that an increase in 
the concentration could saturate the water-air interface, which is a 
behavior common to surfactants, and micelle-like structures were 
observed near 3.5 mg.mL-1 (Figure. 5).  Aggregates are formed at 
lower concentrations of phosphate buffer and accumulate as the 
concentration rises to form micelles (accumulation of 
nanoaggregates). The reason that the results of the pyrene-
fluorimetry and tensiometry aggregation studies differed for NCac 
was that the techniques were based upon different principles. The 
pyrene-based experiments measured the formation of aggregates  
Bassani et al. International Journal of Drug Delivery 5 (2) 214-223 [2013] 
 
PAGE | 220 |
 
 
 
Figure 4. AFM images of NCac at 2.5x2.5 μm and insert: 1.0x1.0 μm, using Mica as support. The samples were prepared using 1mg.mL-1 NCac 
in 0.1 mol.L-1 phosphate saline buffer, pH 7.4. 
 
in solution, which were promoted by the intra and intermolecular 
hydrogen and electrostatic bonds between the NCac chains; this 
effect generates hydrophobic micro-domains in solution. As the 
NCac concentration was further increased, the hydrophobic 
interactions became stronger because acetyl groups were present 
in the chain of NCac and the polarity of the groups available for 
interaction was reduced [33]. Consequently, a second feature in 
the pyrene curve was observed, which was accompanied by a 
significant reduction in the superficial tension (Figure. 5). 
 
Figure 5. Surface tension (mN/m) and pyrene peak ratio (III/I) by 
fluorescence analysis of NCac in 0.1 mol.L-1 phosphate buffer pH 
7.4. 
 
Inter-particle aggregate formation, which was more prevalent in 
CAC than NCac solutions, was also confirmed by AFM imaging 
(Figure. 4B). At the concentration necessary to perform this type of 
imaging, it was no longer possible to observe isolated particles; 
only larger masses formed by the assembly of many NCac 
aggregates were visible. 
 
Incorporation of camptothecin and quantification of drug 
content.  
The therapeutic application of CPT is limited by its low water 
solubility, high toxicity and rapid inactivation (lactone ring 
hydrolysis) at physiological pH. The lactone hydrolysis, which is 
reversible in acidic media, leads to a water-soluble carboxylate. 
However, the carboxylate form is inactive and readily binds to 
human serum albumin, which prevents cellular uptake [34]. 
Methods 1, 2 and 3 increased the amount of CPT entrapped in the 
NCac particles (Table 3). The efficiency of CPT incorporation 
approached 26% and depended on the encapsulation method, 
which suggested that the solubility of the drug was improved by the 
NCac nanoparticles. The co-dispersion of CPT with only the 
polymer did not promote a significant increase in the drug solubility. 
 
Table 3. CPT-loading in NCac by different methods, efficiency of 
drug entrapment and the rate constant (k) for release. 
Samples Loaded CPT 
(μg.mL-1)* 
Efficiency
(%) 
k (h-1)
CPT 2.4μ0.0 1.0 0.09
Method 1 4.7μ0.5 2.3 -
Method 2 52.0μ10.0 26.0 0.01
Method 3 57.6μ8.5 28.8 0.02
* Using 1 mg/mL of polymer and 200 μg.mL-1 of CPT in all the 
methods. 
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If CPT interacts more favorably with the hydrophobic polymer chain 
than with the solvent, the incorporation efficiency will be high, but if 
CPT interacts more significantly with itself, a CPT precipitate will be 
formed [5]. For this work, the ratio of CPT: polymer was 1:5; lower 
CPT content facilitated an increase in the drug loading, which was 
optimal at this proportion. An increase in the concentration did not 
positively influence the efficiency of CPT incorporation (data not 
shown). Mu, Elbayoumi, and Torchilin [35] used a more complex 
system of polymeric micelles; they utilized a mixture of 
polyethyleneglicol, phosphatidylethanolamine and succinate 
tocopherol polietilenglicol and loaded only 30 μ 2 μg of the CPT 
per mL of suspension. Generally, loading CPT into NCac was more 
effective than this or any other previously reported systems [11,35-
37]  
 
Drug release 
 
Kinetic studies of the release of CPT from NCac particles were 
enacted with samples produced by method 2 and 3 of drug-
encapsulation (Figure. 6). Method 1 was not used because of its 
low incorporation of CPT. Identical amounts of CPT were used in 
each encapsulation methodology to quantify the kinetics of CPT 
release. Comparatively, the rate constant k (h-1) for un-chaperoned 
CPT release was 9.4 x 10-2; 1.6 x 10-2 and 2.0 x 10-2 were 
calculated for method 2 and 3 of entrapment, respectively, which 
resulted in k values up to 5.9 times lower (Table 3). These results 
confirm that CPT was incorporated into the particles instead of 
being superficial adsorbed to colloidal particle interfaces. In all 
cases, the R obtained was 0.99, which suggested that a first order 
kinetic model of drug release could be applied to this system. 
 
 
Figure 6. Kinetics of camptothecin (CPT) release from NCac, 
incorporated using two method 2, co-dispersing in DMSO and 
method 3, film formation. The nude CPT was used as reference. 
 
Opanosopit et al. [5] proposed that the weak interactions between 
a drug and the inner core of the encapsulating particles partially 
contribute to faster drug release. This author disclosed that 
increasing the amount of deacetylation to 85% promoted a slower 
release, while less acetylation promoted faster release. 
Additionally, the hydrophobic core of the nanoaggregates could 
facilitate a crystalline structure that includes CPT, which also 
justifies the slow release of the drug from the aggregates [38].  
Several problems, such as recognition by the host immune system, 
occur when the blood-circulation times for particles become long. 
However, the use of biopolymeric particles such as NCac could 
improve biocompatibility and reduce unspecific phagocytosis. The 
slower kinetics of the drug delivery combined with the small size 
(<100 nm) of the NCac particles provide an interesting approach to 
solid tumor treatment; the particles could survive for long periods of 
time in the blood stream and undergo slow deposition in the tumor 
sites. Solid tumors have leaky vasculature and poor lymphatic 
drainage, which should enhance the permeation and the retention 
effects [21]. 
Because tumor sites are also known to be acidic and the particles 
demonstrated less aggregation in acidic media, the drug should be 
released preferentially into the desired locations. Our preliminary 
results indicate that a reduction the pH from 7.4 (normal) to 6.4, 
which is the pH of tumor sites, increases the release of CPT up to 
41.3% (data not shown).  
Conclusion 
NCac forms concentration-dependent structures that include 
nanoaggregates and micelle-like structures; this derivative is a 
good candidate for carrying hydrophobic drugs such as 
camptothecin because the nanoparticles are formed at relatively 
low concentrations, are stable for up to 20 h under physiological 
conditions (phosphate buffer pH 7.4), and can achieve a drug 
loading efficiency of 26%.  A modified kinetic pathway for drug 
delivery was promoted, which made the release of CPT from the 
particles less effective. 
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